Description
Kifaru-50 Tablets (2’s Pack) are oral tablets containing Sildenafil Citrate 50mg, manufactured by Shalina Laboratories Pvt Ltd, India. These tablets are approved by the National Agency for Food and Drug Administration and Control (NAFDAC) in Nigeria, with an approval date of March 29, 2021, and an expiry date of March 28, 2026.
Indications:
-
Erectile Dysfunction (ED): Kifaru-50 is prescribed for adult men to treat erectile dysfunction, a condition characterized by the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
Dosage and Administration:
-
Recommended Dose: The typical starting dose is 50 mg, taken approximately one hour before sexual activity.
-
Adjustments: Depending on efficacy and tolerability, the dose may be increased to 100 mg or decreased to 25 mg.
-
Maximum Dose: The maximum recommended dose is 100 mg per day.
-
Administration: The tablet should be swallowed whole with water. It can be taken with or without food; however, a high-fat meal may delay the onset of action.
Side Effects:
-
Common: Headache, flushing, dyspepsia (indigestion), nasal congestion, dizziness, and visual disturbances.
-
Serious: Rare instances of priapism (prolonged erection), sudden vision loss, or hearing loss. Seek immediate medical attention if any of these occur.
Precautions:
-
Contraindications: Do not use Kifaru-50 if you are taking nitrates or nitric oxide donors, as this can lead to a significant drop in blood pressure.
-
Medical Conditions: Use with caution in individuals with cardiovascular conditions, liver or kidney impairment, or a history of priapism.
-
Drug Interactions: Inform your healthcare provider about all medications you are taking to avoid potential interactions.
Storage:
-
Store in a cool, dry place away from direct sunlight.
-
Keep out of reach of children.
Note: Always consult a healthcare professional before starting any new medication to ensure it is appropriate for your individual health needs.
Reviews
There are no reviews yet.